Press Releases

Vitreoretinal Technologies, Inc. Announces the Enrollment of First Patients for its Phase III Clinical Trial for Vitreosolve for Diabetic Retinopathy Patients in the US and India

Vitreal Retinal Technologies Raises $8.8 Million in a Recent Financing